Table 2 Summary of publications with relevant VCI data
Study | Study design | Country | Years of study | Criterion 1 – Epidemiology | Criterion 4 – Screening | Criteria 9 and 10 – Management pathways |
|---|---|---|---|---|---|---|
Baumfeld 2016 [57] | Retrospective | Israel | 1988 to 2012 | Epidemiology, adverse outcomes | - | - |
Retrospective | USA | 1990 to 2010 | Epidemiology, natural history, adverse outcomes | Test accuracy | [b] | |
Brouillet 2014 [72] | Retrospective | France | 2006 | Epidemiology | - | - |
Bukowski 2017 [60] | Case-control | USA | 2006 to 2008 | Adverse outcomes | - | - |
Chu 2013 [61] | Retrospective | USA | 2010 to 2011 | Adverse outcomes | - | - |
Cirstoiu 2016 [40] | Retrospective | Romania | 2010 to 2016 | Epidemiology, adverse outcomes | - | - |
Costa-Castro 2013 [42], Lopriore 2007 [73], Lopriore 2012 [74] | Retrospective | Portugal, the Netherlands | 2002 to 2012 | Epidemiology, adverse outcomes | - | - |
Costa-Castro 2016 [44] | Retrospective | Portugal, the Netherlands | 2005 to 2015 | Epidemiology, adverse outcomes | - | - |
Couck 2018 [75] | Retrospective | Belgium | 2002 to 2016 | Epidemiology | - | - |
Prospective | USA | 2001 to 2008 | Epidemiology | - | - | |
De Paepe 2011 [46] | Prospective | USA | 2009 to 2011 | Epidemiology | - | - |
Di Salvo 1998 [63] | Prospective | USA | 1992 to 1995 | Epidemiology [a] | Test accuracy | - |
Retrospective | Norway | 1999 to 2011 | Epidemiology, adverse outcomes | - | - | |
Hack 2008 [58] | Prospective | The Netherlands | 1998 to 2007 | Epidemiology, adverse outcomes | - | - |
Hack 2009 [48] | Prospective | The Netherlands | 1998 to 2008 | Epidemiology, adverse outcomes | - | - |
Prospective, retrospective | Japan | 2002 to 2004 | Epidemiology, adverse outcomes [a] | Test accuracy | - | |
Retrospective cohort | Japan | 2005 to 2006 | Epidemiology, adverse outcomes | - | - | |
Hasegawa 2011 [39] | Retrospective cohort | Japan | 2006 to 2009 | Epidemiology | - | - |
Heller 2014 [50] | Retrospective | USA | 2007 to 2011 | Epidemiology, adverse outcomes | - | - |
Ismail 2017 [62] | Prospective | Ireland | 2016 | Epidemiology, adverse outcomes | - | - |
Kalafat 2018 [38] | Retrospective | UK | 2000 to 2016 | Epidemiology | - | - |
Kanda 2011 [51] | Retrospective | Japan | 2002 to 2007 | Epidemiology, adverse outcomes | Test accuracy | [b] |
Kent 2011 [47] | Prospective | Ireland | 2007 to 2009 | Epidemiology, adverse outcomes | - | - |
Lepais 2014 [78] | Retrospective | France | 2005 to 2009 | Epidemiology | - | - |
McNamara 2014 [6] | Retrospective | Canada | 1978 to 2007 | Epidemiology, adverse outcomes | - | - |
Melcer 2017 [55] | Retrospective | Israel | 2005 to 2016 | Epidemiology | - | - |
Nomiyama 1998 [66] | Prospective | Japan | 1993 to 1996 | Epidemiology [a] | Test accuracy | - |
Pinar 2014 [59] | Case-control | USA | 2006 to 2008 | Epidemiology | - | - |
Pretorius 1996 [16] | Prospective | USA | 1992 to 1993 | Epidemiology [a] | Test accuracy | - |
Raisanen 2012 [7] | Retrospective | Finland | 2000 to 2011 | Epidemiology, adverse outcomes | - | - |
Rebarber 2014 [52] | Retrospective | USA | 2005 to 2012 | Epidemiology, natural history, adverse outcomes | - | [b] |
Sepulveda 2006 [67] | Prospective | Chile | NR | Epidemiology [a] | Test accuracy | - |
Sepulveda 2003 [68] | Prospective | Chile | 2001 to 2002 | Epidemiology [a] | Test accuracy | - |
Smorgick 2010 [53] | Retrospective | Israel | 1998 to 2007 | Epidemiology, adverse outcomes | - | - |
Suzuki 2015 [8] | Prospective | Japan | 2002 to 2011 | Epidemiology, adverse outcomes | - | - |
Swank 2016 [54] | Retrospective | USA | 2000 to 2012 | Epidemiology, natural history, adverse outcomes | - | - |
Walker 2012 [79] | Retrospective | Canada | 2000 to 2010 | Epidemiology | - | - |
Waszak 2016 [43] | NR | Poland | NR | Epidemiology, adverse outcomes | - | - |
Yanaihara 2018 [41] | NR | Japan | 2015 to 2017 | Epidemiology | - | - |
Yerlikaya 2016 [9] | Case-control | Austria | 2003 to 2013 | Epidemiology, adverse outcomes | - | - |